BAXTER INTERNATIONAL INC 4
4 · BAXTER INTERNATIONAL INC · Filed Jul 6, 2015
Insider Transaction Report
Form 4
PARKINSON ROBERT L JR
DirectorChairman of the Board & CEO
Transactions
- Other
Stock Option (Right to Buy)
2015-07-01+455,600→ 987,161 totalExercise: $37.38Exp: 2025-03-03→ Common Stock, par value $1.00 per share (455,600 underlying) - Other
Common Stock, par value $1.00 per share
2015-07-01+60,584→ 683,316 total
Holdings
- 384,000
Stock Option (Right to Buy)
Exercise: $27.58Exp: 2017-03-15→ Common Stock, par value $1.00 per share (384,000 underlying) - 263,989
Stock Option (Right to Buy)
Exercise: $31.77Exp: 2020-03-03→ Common Stock, par value $1.00 per share (263,989 underlying) - 399,088
Stock Option (Right to Buy)
Exercise: $37.82Exp: 2023-03-05→ Common Stock, par value $1.00 per share (399,088 underlying) - 546,000
Stock Option (Right to Buy)
Exercise: $20.65Exp: 2016-03-14→ Common Stock, par value $1.00 per share (546,000 underlying) - 304,000
Stock Option (Right to Buy)
Exercise: $31.30Exp: 2018-03-05→ Common Stock, par value $1.00 per share (304,000 underlying) - 254,400
Stock Option (Right to Buy)
Exercise: $28.27Exp: 2019-03-04→ Common Stock, par value $1.00 per share (254,400 underlying) - 330,852
Stock Option (Right to Buy)
Exercise: $28.97Exp: 2021-03-04→ Common Stock, par value $1.00 per share (330,852 underlying) - 393,379
Stock Option (Right to Buy)
Exercise: $37.17Exp: 2024-03-04→ Common Stock, par value $1.00 per share (393,379 underlying) - 383,511
Stock Option (Right to Buy)
Exercise: $30.95Exp: 2022-03-06→ Common Stock, par value $1.00 per share (383,511 underlying)
Footnotes (7)
- [F1]In connection with the spin-off (the "Spin-off") of Baxalta Incorporated ("Baxalta") from Baxter International Inc. ("Baxter"), the reporting person received a grant of 60,584 restricted stock units as a result of the adjustment of existing Baxter restricted stock units held by the reporting person prior to the Spin-off. The restricted stock units will vest in three equal annual installments beginning on March 3, 2016, the first anniversary of the grant date of the existing award.
- [F2]Represents options to purchase Baxter common stock awarded to the reporting person prior to the Spin-off. In connection with the Spin-off, the exercise price of the option was adjusted, and the reporting person received options to purchase shares of Baxalta common stock, to preserve the pre-Spin-off intrinsic value of the existing Baxter option award.
- [F3]This option is presently exercisable in full.
- [F4]Two-thirds of this option is presently exercisable. The remaining one third becomes exercisable on March 5, 2016.
- [F5]One-third of this option is presently exercisable. The remaining two thirds become exercisable on March 4, 2016 and March 4, 2017.
- [F6]In connection with the Spin-off, the number of shares subject to this option and the exercise price have been adjusted to preserve the pre-Spin-off intrinsic value of the existing Baxter option award.
- [F7]This option will vest in three equal annual installments beginning on March 3, 2016, the first anniversary of the grant date of the existing option award.